Usa India testing vaccine Coronavirus Usa India

Pfizer, BioNTech begin Covid vaccine trial in children under 12

Reading now: 371
www.livemint.com

coronavirus vaccine in children under 12, an early sign of the next stage of the global immunisation campaign."Together with our partner BioNTech, we have dosed the first healthy children in a global Phase 1/2/3 continuous study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine," the company said in a statement to news agency AFP."We are proud to start this much-needed study for children and families eagerly awaiting a possible vaccine option," the US drugmaker added.According to details posted on the site clinicaltrials.gov, the company is testing three different dosing levels - 10, 20 and 30 micrograms - in a 144-participant Phase I/II trial for use in this age group, with hopes of.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA